McKesson/Celesio Deal Targets Generics Purchasing Synergies
This article was originally published in The Pink Sheet Daily
Executive Summary
McKesson believes its acquisition of European drug wholesaler Celesio will result in $275 million to $325 million in synergies four years out, and much of the savings will be achieved through generic drug purchasing.